A Colonoscopy Alternative Comes Home (The New York Times) 0 By Praveen Suthrum on October 10, 2022 Gastroenterology Industry Share Facebook Twitter LinkedIn Pinterest Email An at-home test for colon cancer is as reliable as the traditional screening, health experts say, and more agreeable. read more
Liquid Biopsy-Based Colorectal Cancer Screening Lacks Cost-Effectiveness, Economic Analysis Finds (GenomeWeb)
Takeda scores FDA green light for colorectal cancer drug Fruzaqla, 10 months after acquiring its rights in $1.1B deal with Hutchmed (Fierce Pharma)